Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Regulatory services specific to Europe
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / Articles / Seal the Deal: Avoid These Corporate Development Mistakes

Seal the Deal: Avoid These Corporate Development Mistakes

Facebook0
Google+0
LinkedIn0
Twitter0

By Kevin Closson, Nerac Analyst,

Originally published October, 2013

Corporate development is extremely risky. The stats from numerous studies are dismal:

  • Anywhere between 50 percent and 90 percent of acquisitions fail to live up to financial expectations;
  • Mergers fail between 50 percent and 85 percent of the time;
  • Joint ventures are only slightly less dreary; they fall apart between 30 percent and 60 percent of the time.

Yet despite these bleak odds, companies and the executives running them remain undeterred. The overwhelming majority of successful private company exits in 2012 and 2013 were not IPOs but rather mergers, acquisitions or sales. This is a historical trend that is unlikely to change in the future.

Want to read the rest of the article? Fill out the form to download: Seal the Deal: Avoid These Corporate Development Mistakes
Get Download Link

 

Related Posts

  • Nerac's Corporate Video
    36
    Tags: corporate
  • The importance of innovation.
    36
    The early stages of innovation and new product development are critical....find out why. Have a question for Kevin? Let us know!  
    Tags: development, kevin
  • Kevin Bouley, Nerac CEO, tapped for multiple mentorship and judging roles at UConn
    36
    Schools of Engineering and Nursing along with campus-wide iQ program at UConn leverage entrepreneur’s extensive business development experience Read the full release here.
    Tags: read, full, development, nerac, kevin, published, originally
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence conflict minerals Disruptive Technologies emerging markets energy EU MDR FDA food Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies Internet of Things IP Lactation Innovations LLC market analysis medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance specialty chemicals Sustainable Development Goals technology scouting Tech Scouting XcellR8
  • Facebook
  • Google+
  • Linkedin
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities

Copyright © 2019 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.